In September, the listed company Yuwell Medical announced it has completed the acquisition of 50.993% equity in Zhejiang POCTech Co., Ltd. After this acquisition transaction, Yuwell Medical holds 50.993% of the equity of POCTech, and POCTech will be part of the consolidated statement of Yuwell Medical.
Established in 2010, POCTech is committed to R&D, production, and sales of medical portable monitoring systems with high-end biosensors as the core technology, including dynamic blood glucose monitoring (CGM), blood gas and electrolytes, and other POCT instant inspection products. It has become the industry's leading technology innovator and leader by providing comprehensive, effective and economical diabetes management program in this area.
As an A-share listed company, Yuwell Medical has established a professional all-round medical service platform since 1998. After the completion of this acquisition, POCTech can rely on Yuwell Medical's large-scale, intelligent, and lean production capacity and also coordinate their sales resources, software development resources and user operations to realize the efficient maximization.
